Cargando…

High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer

We have previously identified a novel intra-tumoral dichotomy in triple-negative breast cancer (TNBC) based on the differential responsiveness to a reporter containing the Sox2 regulatory region-2 (SRR2), with reporter responsive (RR) cells being more stem-like than reporter unresponsive (RU) cells....

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Nidhi, Jung, Karen, Wu, Chengsheng, Alshareef, Abdulraheem, Alqahtani, Hind, Damaraju, Sambasivarao, Mackey, John R., Ghosh, Sunita, Sabri, Siham, Abdulkarim, Bassam S., Bigras, Gilbert, Lai, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438634/ https://www.ncbi.nlm.nih.gov/pubmed/28427212 http://dx.doi.org/10.18632/oncotarget.15891

Ejemplares similares

Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporter
por: Gopal, Keshav, et al.
Publicado: (2015)

Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays
por: Jung, Karen, et al.
Publicado: (2014)

Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features
por: Gupta, Nidhi, et al.
Publicado: (2018)

Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma
por: Wu, Chengsheng, et al.
Publicado: (2018)

Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer
por: Krishnan, Preethi, et al.
Publicado: (2016)

Genome-wide profiling of transfer RNAs and their role as novel prognostic markers for breast cancer
por: Krishnan, Preethi, et al.
Publicado: (2016)

Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis
por: Krishnan, Preethi, et al.
Publicado: (2016)

Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter
por: Jung, Karen, et al.
Publicado: (2015)

Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility
por: Sehrawat, Badan, et al.
Publicado: (2011)

A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma
por: Wu, Chengsheng, et al.
Publicado: (2016)

Germline DNA Copy Number Aberrations Identified as Potential Prognostic Factors for Breast Cancer Recurrence
por: Sapkota, Yadav, et al.
Publicado: (2013)

Fine‐mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women
por: Kumaran, Mahalakshmi, et al.
Publicado: (2019)

High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma
por: Alshareef, Abdulraheem, et al.
Publicado: (2017)

Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic
por: Bian, David J. H., et al.
Publicado: (2022)

Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer
por: Krishnan, Preethi, et al.
Publicado: (2015)

Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma
por: Chaddad, Ahmad, et al.
Publicado: (2019)

Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia
por: Narasimhan, Ashok, et al.
Publicado: (2017)

ETHNOPRED: a novel machine learning method for accurate continental and sub-continental ancestry identification and population stratification correction
por: Hajiloo, Mohsen, et al.
Publicado: (2013)

The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics
por: Krishnan, Preethi, et al.
Publicado: (2018)

PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease
por: Assaker, Gloria, et al.
Publicado: (2019)

A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
por: Sapkota, Yadav, et al.
Publicado: (2012)

New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma
por: Bigras, Gilbert, et al.
Publicado: (2018)

Spontaneous Epithelial-Mesenchymal Transition and Resistance to HER-2-Targeted Therapies in HER-2-Positive Luminal Breast Cancer
por: Lesniak, David, et al.
Publicado: (2013)

Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
por: Daniel, Paul, et al.
Publicado: (2019)

The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer
por: Pandya, Vrajesh, et al.
Publicado: (2016)

Novel Molecular Challenges in Targeting Anaplastic Lymphoma Kinase in ALK-Expressing Human Cancers
por: Alshareef, Abdulraheem
Publicado: (2017)

Germline copy number variations are associated with breast cancer risk and prognosis
por: Kumaran, Mahalakshmi, et al.
Publicado: (2017)

Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer
por: Oweida, Ayman, et al.
Publicado: (2017)

Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation
por: Chaddad, Ahmad, et al.
Publicado: (2019)

SYST-08. A phase II trial of concurrent Sunitinib, Temozolomide and Radiation Therapy followed by adjuvant Temozolomide for newly diagnosed Glioblastoma patients with an unmethylated MGMT gene promoter (A01-M121-11A, McG1132)
por: Faye, Mame Daro, et al.
Publicado: (2021)

Identification of a Breast Cancer Susceptibility Locus at 4q31.22 Using a Genome-Wide Association Study Paradigm
por: Sapkota, Yadav, et al.
Publicado: (2013)

Breast cancer prediction using genome wide single nucleotide polymorphism data
por: Hajiloo, Mohsen, et al.
Publicado: (2013)

MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer
por: Doha, Zinab O., et al.
Publicado: (2023)

Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumour heterogeneity
por: Fonseka, Pamali, et al.
Publicado: (2019)

BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer
por: Pandya, Vrajesh, et al.
Publicado: (2020)

N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target
por: Mackey, John R., et al.
Publicado: (2021)

Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia
por: Narasimhan, Ashok, et al.
Publicado: (2017)

Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models
por: VanderSluis, Laura, et al.
Publicado: (2017)

Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity
por: Lam, K. H. Brian, et al.
Publicado: (2022)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_87c04ntfbujfgfnubm7nu9f5ri